These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Good use of blood transfusions: principal indications for hemotherapy]. Goudemand M; Bauters F; Parquet-Gernez A Lille Med; 1974; 19 Spec No():377-85. PubMed ID: 4437301 [No Abstract] [Full Text] [Related]
6. [Targetted hemotherapy with special reference to the cellular components]. Dörner R Dtsch Med Wochenschr; 1990 Jul; 115(27):1066-72. PubMed ID: 2194776 [No Abstract] [Full Text] [Related]
7. Transfusion therapy for patients with cancer. Lichtiger B; Huh YO CA Cancer J Clin; 1985; 35(5):311-6. PubMed ID: 3930017 [No Abstract] [Full Text] [Related]
8. Fresh-frozen plasma vs. plasma protein derivative as adjunctive therapy for patients with massive burns. Alexander JW; Ogle CK; Stinnett JD; White M; MacMillan BG; Edwards BK J Trauma; 1979 Jul; 19(7):502-11. PubMed ID: 458893 [TBL] [Abstract][Full Text] [Related]
9. Whole blood vs. packed red cells for resuscitation of hemorrhagic shock: an examination of host defense parameters in dogs. Beiting CV; Kozak KJ; Dreffer RL; Stinnett JD; Alexander JW Surgery; 1978 Aug; 84(2):194-200. PubMed ID: 684611 [TBL] [Abstract][Full Text] [Related]
10. The role of host defense mechanisms in surgical infections. Alexander JW Surg Clin North Am; 1980 Feb; 60(1):107-16. PubMed ID: 7361215 [TBL] [Abstract][Full Text] [Related]
11. [Blood components and preparations]. Gorodetskiĭ VM Feldsher Akush; 1981; 46(5):46-50. PubMed ID: 6910443 [No Abstract] [Full Text] [Related]
12. Plasma fibronectin: a third opsonic protein involved in immune clearance and destruction of erythrocytes after infusion of incompatible blood. Hathaway TK; Adams JL Transplant Proc; 1988 Dec; 20(6):1096-102. PubMed ID: 3144069 [No Abstract] [Full Text] [Related]
14. [Possibilities and limits of modern hemotherapy]. István L Orv Hetil; 1978 Dec; 119(50):3043-54. PubMed ID: 733225 [No Abstract] [Full Text] [Related]
15. The blood components--advancement in haemotherapy. Nathan IV; Han P J Singapore Paediatr Soc; 1986; 28(3-4):216-26. PubMed ID: 3599928 [No Abstract] [Full Text] [Related]
16. The effect of peripheral blood components on allograft survival. Wakely E; Shelby J; Corry RJ Transplantation; 1985 Jul; 40(1):113-4. PubMed ID: 3892790 [No Abstract] [Full Text] [Related]
18. [Blood transfusions and component therapy in clinical practice]. Korolev SS Med Sestra; 1981 Nov; 40(11):41-7. PubMed ID: 6915347 [No Abstract] [Full Text] [Related]
19. Granulocyte transfusion therapy. Thrash V; Stone MJ; Frenkel EP South Med J; 1977 Mar; 70(3):339-43. PubMed ID: 322298 [No Abstract] [Full Text] [Related]
20. Effect of transfusions on serologic testing for antibody to varicella. Taylor-Wiedeman J; Brunell PA; Geiser C; Shehab ZM; Frierson LS Med Pediatr Oncol; 1986; 14(6):316-8. PubMed ID: 3023802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]